0001534969-24-000073.txt : 20240328
0001534969-24-000073.hdr.sgml : 20240328
20240328175640
ACCESSION NUMBER: 0001534969-24-000073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240327
FILED AS OF DATE: 20240328
DATE AS OF CHANGE: 20240328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boniface John J.
CENTRAL INDEX KEY: 0001870674
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40606
FILM NUMBER: 24800928
MAIL ADDRESS:
STREET 1: C/O SERA PROGNOSTICS, INC.
STREET 2: 2749 EAST PARLEYS WAY, SUITE 200
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SERA PROGNOSTICS, INC.
CENTRAL INDEX KEY: 0001534969
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 261911522
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2749 E. PARLEYS WAY
STREET 2: SUITE 200
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84109
BUSINESS PHONE: (801) 990-0520
MAIL ADDRESS:
STREET 1: 2749 E. PARLEYS WAY
STREET 2: SUITE 200
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84109
4
1
wk-form4_1711662978.xml
FORM 4
X0508
4
2024-03-27
0
0001534969
SERA PROGNOSTICS, INC.
SERA
0001870674
Boniface John J.
C/O SERA PROGNOSTICS, INC.
2749 EAST PARLEYS WAY, SUITE 200
SALT LAKE CITY
UT
84109
0
1
0
0
Chief Scientific Officer
1
Class A Common Stock
2024-03-27
4
S
0
3753
9.62
D
139771
D
Class A Common Stock
2024-03-27
4
M
0
48909
0.91
A
188680
D
Class A Common Stock
2024-03-27
4
S
0
48909
9.62
D
139771
D
Class A Common Stock
2024-03-28
4
M
0
24474
0.91
A
164245
D
Class A Common Stock
2024-03-28
4
S
0
24474
9.04
D
139771
D
Stock Option (right to buy)
0.91
2024-03-27
4
M
0
48909
0
D
2024-12-29
Class A Common Stock
48909
24474
D
Stock Option (right to buy)
0.91
2024-03-28
4
M
0
24474
0
D
2024-12-29
Class A Common Stock
24474
0
D
The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.06 to $9.85, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.58 to $9.24, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
The shares subject to this option are fully vested and exercisable.
/s/ Benjamin G. Jackson, Attorney-in-fact
2024-03-28